Navigation Links
An Anti-cancer Smart Bomb delivered using a Nanocell

A nanocell that can work like a smart bomb for cancer treatment is to be reported in Nature by MIT. The nanocell will work by penetrating into the tumor, seal the opening and then deliver the lethal dose of anti-cancer toxins like a ‘stealth bimb’.// This will leave the healthy cells unharmed.

The experiments currently done on mice cancer like melanoma and lung cancer have the potential of being a revolutionary form of drug delivery mechanism in cancers. The drugs that can kill cancer cells are available however they cannot be given in a high dose due to their side effects. However the double-acting, drug-packing "nanocell" can prove to be effective and safe and prolong survival of cancers.

This study reported in the July 28 issue of Nature has the following discussion:
"We brought together three elements: cancer biology, pharmacology and engineering," said Ram Sasisekharan, a professor in MIT's Biological Engineering Division and leader of the research team.

"The fundamental challenges in cancer chemotherapy are its toxicity to healthy cells and drug resistance by cancer cells," Sasisekharan said. "So cancer researchers were excited about anti-angiogenesis," the theory that cutting off the blood supply can starve tumors to death. That strategy can backfire, however, because it also starves tumor cells of oxygen, prompting them to create new blood vessels and instigate metastasis and other self-survival activities.

The next obvious solution would be combining chemotherapy and anti-angiogenesis-dropping the bombs while cutting the supply lines. But combination therapy confronted an inherent engineering problem. "You can't deliver chemotherapy to tumors if you have destroyed the vessels that take it there," Sasisekharan said. Also, the two drugs behave differently and are delivered on different schedules: anti-angiogenics over a prolonged period and chemotherapy in cycles.

"We designed the
'"/>




Page: 1 2 3

Related medicine news :

1. Anti-cancer drug may treat muscular dystrophy
2. Gene Study Offers Hope of Potent Anti-cancer Drugs
3. Indian Court Refers Novartis Plea for Patent on Anti-cancer Drug to a Separate Board
4. Smart Plastic As Surigical Thread
5. Music Makes you Smarter
6. Smart drugs for alcohol hangovers not effective
7. Need For Smarter Ways To Identify Fake Drugs & Internet Counterfeiting: WHO
8. Goodbye, Blue Smarties
9. Government Considering Of Issuing ‘Smart Cards’ For HIV/AIDS Patiens
10. Sex Workers To Have Smart Health Card
11. Snack Smart To Avoid Obesity
Post Your Comments:
(Date:9/5/2008)...dy finds sorafenib helps reverse disease resistanc...ept. 5 (HealthDay News) -- The drug sorafenib may ...o anti-hormonal drugs, Georgetown University Medi...en-receptor or progesterone-receptor positive (ER ...ke anti-hormonal medicines, such as aromatase inhi...
(Date:9/5/2008)... New York Fashion Week,s Annual Desti... New York, New York (PRWEB) September 5, 200...r Centers __title__ American Laser], the largest p...e aesthetic services in the U.S., announces sponso... Week. STYLE360, from Sept. 7-10, serves as the a...
(Date:9/4/2008)...3, 2008In a case-control study, the presence of me...h autism and GI disturbances than in children with...d autism onset were unrelated to MMR vaccine timin...lic Library of Science on September 4 ( http://dx...r to the implementation of measles vaccines in 196...
(Date:9/4/2008)...nt stronger labeling about fungal infection risk ...- Federal health authorities have asked the manufa...s to bolster safety warnings on the risk of develo...gs, Humira, Cimzia, Enbrel and Remicade, belong to...ctor alpha blockers (TNF-alpha blockers), which su...
Breaking Medicine News(10 mins):Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 3
...e fixed on Boeing here Sunday when the US aircraft...ssenger jet it hopes will revolutionize air travel...engers and is capable of flying long-haul routes u...e pumping out fewer greenhouse gases, will be roll...
...ciers are receding and lakes are drying up in Lati...en while some sections are adamantly skeptical abo...rted the disappearance of a whole lake in the sout...lake, some 20,000 square metres in area, in the Be...
... is also draconian. Any presumed violation of the ...commercial fishing pond in Pasir Ris Drive 6, will...eding mosquitoes. The area is dubbed the number on...the nation, reporting close to 40 new cases as of ...
...ljana in Slovenia have solved the mystery behind w...fore their eyes. Samo and Marko Kreft of the u...d oil, say that it happens due to the unique makeu...specific physical properties of substances themsel...
Other Medicine News:Health News:Boeing Unveils 'green' Dreamliner Passenger Jet 2Health News:Chilean Lake Disappears, Thanks to Global Warming 2Health News:Dengue Surge in Singapore, Man Prosecuted for Breeding Mosquitoes 2
(Date:9/4/2008)...wswire/ -- Southern Research Institute,today annou...has selected,the organization to participate in th...n Center Network (MLPCN). The MLPCN -- a collabora...Libraries Program which is,designed to benefit hum...an,genome and validate future targets for drug dis...
(Date:9/4/2008)...4 /- Axentis Pharma AG has,initiated ...d tolerability,of a new therapeutic formulation fo...ystic fibrosis patients. The new formulation allow... directly to the site of,infection. The forthcomin...rent doses of the new drug. Initial results are ex...
(Date:9/4/2008)... antiviral activity and favorable safety ... Sept. 4 /- Idenix,Pharmace...l company engaged,in the discovery and development...er infectious diseases, today announced that it ha...IDX899, a non-nucleoside reverse,transcriptase inh...
(Date:9/4/2008)...edule with Two Abstracts Accepted for Presenta...2008, BRIDGEWATER, N.J., Sept. 4 /- ...ceutical company focused on the treatment of,cardi...he appointment of,Peter L. Garrambone, Jr. to the ... career includes more than 50 pharmaceutical,trans...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Oncolytics Biotech Inc Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 5470 1Oncolytics Biotech Inc Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 5470 2Tempo Participacoes Announces Increase of 34 25 in EBITDA and of 25 25 in Net Revenue for the 1Q08 19574 1ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 1ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 2ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 3ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 4ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 1Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 6
...as--(BUSINESS WIRE)--Jun 11, 2007 - Repros,Therape... findings,from its six month study of Proellex in ...ted in Europe, enrolled 39,premenopausal women and...luded three dose levels of Proellex(TM) as well as...Lucrin(R), a GnRH,agonist also known as Lupron(R) ...
...on of Phase II Study Demonstrates Significant,Addi...NGTON, Mass., June 12, 2007 /PRNewswire-FirstCall/...that results from the,Company,s Phase II EXPRESS t...ttering will be presented today at the 47th annual...(NCDEU), sponsored,by National Institute for Menta...
Other Medicine Technology:Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 2Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 4Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 5Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 2Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 4Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 5Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 7Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 8Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 9
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: